Literature DB >> 29407051

Hyperglycemia in Acute Coronary Syndromes: From Mechanisms to Prognostic Implications.

Mikhail Kosiborod1.   

Abstract

Numerous studies have documented that hyperglycemia is frequent in patients hospitalized with acute coronary syndromes, affects patients with and without established diabetes, and is associated with adverse outcomes, with incremental increase in risk of mortality and complications observed across the spectrum of glucose elevations. This article reviews present knowledge about the association between glucose levels and outcomes of patients hospitalized with acute coronary syndromes; describes available data regarding inpatient glucose management in this patient group, and comparative data across the spectrum of critically ill hospitalized patients; addresses some controversies in this field; and offers practical recommendations for patient management based on existing data.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetes; Glucose; Insulin; Myocardial infarction; Review

Mesh:

Substances:

Year:  2018        PMID: 29407051     DOI: 10.1016/j.ecl.2017.11.002

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  9 in total

1.  Cardiometabolic medicine: time to recognize a new clinical specialty?

Authors:  Andrew J Krentz; Stephan Jacob
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-05-15

2.  Evaluation of cardiometabolic risk markers linked to reduced left ventricular ejection fraction (LVEF) in patients with ST-elevation myocardial infarction (STEMI).

Authors:  Marjan Mahdavi-Roshan; Zeinab Ghorbani; Mahboobeh Gholipour; Arsalan Salari; Amir Savar Rakhsh; Jalal Kheirkhah
Journal:  BMC Cardiovasc Disord       Date:  2022-05-14       Impact factor: 2.174

Review 3.  The extended autonomic system, dyshomeostasis, and COVID-19.

Authors:  David S Goldstein
Journal:  Clin Auton Res       Date:  2020-07-22       Impact factor: 4.435

4.  Hyperglycaemia, adverse outcomes and impact of intravenous insulin therapy in patients presenting with acute ST-elevation myocardial infarction in a socioeconomically disadvantaged urban setting: The Montefiore STEMI Registry.

Authors:  Sanyog G Shitole; Vankeepuram Srinivas; Julia L Berkowitz; Tina Shah; Michael J Park; Samuel Herzig; Anne Christian; Neeral Patel; Xiaonan Xue; James Scheuer; Jorge R Kizer
Journal:  Endocrinol Diabetes Metab       Date:  2019-08-14

5.  Maximum blood glucose levels during hospitalisation to predict mortality in patients with acute coronary syndrome: a retrospective cohort study.

Authors:  Jun Qian; Lijun Kuang; Lin Che; Fei Chen; Xuebo Liu
Journal:  BMJ Open       Date:  2020-12-12       Impact factor: 2.692

6.  Effects of diabetes mellitus complicated by admission hyperglycemia on clot histological composition and ultrastructure in patients with acute ischemic stroke.

Authors:  Jun Lu; Juan Chen; Daming Wang; Qun Gao; Peng Qi; Junjie Wang; Shen Hu; Ximeng Yang; Jingwen Fan; Ling Li; Yao Lu
Journal:  BMC Neurol       Date:  2022-04-05       Impact factor: 2.474

7.  Effect of Admission Hyperglycemia on Short-Term Prognosis of Patients with Non-ST Elevation Acute Coronary Syndrome without Diabetes Mellitus.

Authors:  Wei Liu; Zhijuan Li; Shiying Xing; Yanwei Xu
Journal:  J Diabetes Res       Date:  2021-12-06       Impact factor: 4.011

8.  Body Mass Index Enhances the Associations Between Plasma Glucose and Mortality in Patients with Acute Coronary Syndrome.

Authors:  Jing Wen; Liu He; Xin Du; Chang-Sheng Ma
Journal:  Diabetes Metab Syndr Obes       Date:  2022-08-31       Impact factor: 3.249

9.  Admission hyperglycemia as an independent predictor of long-term prognosis in acute myocardial infarction patients without diabetes: A retrospective study.

Authors:  Cai-Yan Cui; Ming-Gang Zhou; Lian-Chao Cheng; Tao Ye; Yu-Mei Zhang; Feng Zhu; Si-Yi Li; Xing-Lin Jiang; Qiang Chen; Ling-Yao Qi; Xu Chen; Si-Qi Yang; Lin Cai
Journal:  J Diabetes Investig       Date:  2020-12-28       Impact factor: 4.232

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.